Mikael Von Euler
Consultant
Medical Adviser
Apera Therapeutics Company
Sweden
Biography
Dr. von Euler is a medical oncologist with more than 25 years of experience in the pharmaceutical industry and was formerly Chief Medical Officer at Aprea Therapeutics. He was also Chief Medical Officer at Oncos Therapeutics, where he continues to serve as a Medical Adviser. Dr. von Euler has also served as Cluster Head for the Her2 area (Herceptin, pertuzumab, T-DM1) at Roche/Genentech, Vice President of Oncology Europe at GlaxoSmithKline and Global Product Director of Arimidex/Nolvadex at AstraZeneca. Dr. von Euler received his MD and PhD degrees from the Karolinska Institute in Stockholm, Sweden.
Research Interest
Environmental & Analytical Toxicology, Medical Toxicology and Clinical Forensic Medicine
